the general consensus was that the drug class was an R&D dead end. Merck's exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Raymond James bullish rating for Bausch Health Companies remains unchanged after a U.S. District Court ruling.

Price, aged 31, was found with found cocaine and cannabis. The estimated street value of the drugs seized was around £7,500. Stacey Culvin and Sharnie Price The pair were arrested and charged ...

Price, aged 31, was found with found cocaine and cannabis. The estimated street value of the drugs seized was around £7,500. Stacey Culvin and Sharnie Price The pair were arrested and charged ...

The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global ...

On Thursday, April 10, officers in the south west of the city recovered the Class-A drugs worth an estimated street value of £50,000 from an address in Dumbeg Park, Edinburgh. This was in ...

Alvo­gen plans to fight a court de­ci­sion that could sig­nif­i­cant­ly de­lay its abil­i­ty to bring a gener­ic ver­sion of Bausch Health’s Xi­fax­an to mar­ket, the … ...

Pet owners who say their dogs experienced adverse effects or died after being treated with osteoarthritis drug, Beransa, are preparing a class action. But Australian veterinarians say the drug has ...

TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

Xifaxan 550-milligram tablet, as a federal judge said it “needs a time machine ... Norwich, an Alvogen Group Inc. subsidiary, sued the US Food and Drug Administration in January alleging the decision ...